mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.04 |